Is this good=bye?

You will leaving

Life Sciences

Life sciences companies face a range of challenges and opportunities. Our team of industry specialists can help you map out risk strategies and approaches as new issues emerge.

Life sciences companies today are faced with a range of challenges. From litigation and the actions of regulators posing a financial and reputational risk, to successful challenges to patents and other forms of intellectual property potentially undermining a firm’s core product and source of revenue. At the same time, insurers are increasingly restricting product liability insurance cover for life sciences companies.

Our understanding of the special risks facing life sciences companies has helped make us one of the leading agents/brokers servicing the sector, giving you access to a creative and expanding range of solutions in pharmaceutical, drug wholesale, nutraceutical, biotechnology, medical device and supply, and contract research. In partnership with our wider network of Marsh & McLennan Companies, we provide solutions and services such as:

  • Business risk consulting.
  • Supply chain management.
  • Clinical trials risk.
  • Business continuity/resiliency/crisis management.

Marsh has created centres of excellence to aggregate our knowledge and expertise of the industry, enabling us to keep you abreast of current trends impacting the industry and provide insights in areas of program design, placement, service, and administration.

By helping reduce your total cost of risk with tailored solutions – insurance brokerage, advisory, and risk management services – Marsh can help you minimize the volatility and severity of risk, protect assets, and maintain profitability.

Some services and insurance products may not be available in Japan. Please contact our office for details.

Our expertise

Related articles